.png){kind=icon}
返回
Childhood stroke
.png){kind=icon}
PRE
AI
DOI：10.1038/s41572-022-00337-x.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
This Primer summarizes the mechanisms, epidemiology, diagnosis and treatment of stroke in children (that is, stroke occurring in those aged between 29 days and 18 years). Stroke is an important cause of neurological morbidity in children; most survivors have permanent neurological deficits that affect the remainder of their life. Stroke in childhood, the focus of this Primer, is distinguished from perinatal stroke, defined as stroke before 29 days of age, because of its unique pathogenesis reflecting the maternal-fetal unit. Although approximately 15% of strokes in adults are haemorrhagic, half of incident strokes in children are haemorrhagic and half are ischaemic. The causes of childhood stroke are distinct from those in adults. Urgent brain imaging is essential to confirm the stroke diagnosis and guide decisions about hyperacute therapies. Secondary stroke prevention strongly depends on the underlying aetiology. While the past decade has seen substantial advances in paediatric stroke research, the quality of evidence for interventions, such as the rapid reperfusion therapies that have revolutionized arterial ischaemic stroke care in adults, remains low. Substantial time delays in diagnosis and treatment continue to challenge best possible care. Effective primary stroke prevention strategies in children with sickle cell disease represent a major success, yet barriers to implementation persist. The multidisciplinary members of the International Pediatric Stroke Organization are coordinating global efforts to tackle these challenges and improve the outcomes in children with cerebrovascular disease.
Keyword:
ARTERIAL ISCHEMIC-STROKE
CEREBRAL CAVERNOUS MALFORMATIONS
BRAIN ARTERIOVENOUS-MALFORMATIONS
HEREDITARY HEMORRHAGIC TELANGIECTASIA
QUALITY-OF-LIFE
TRANSCRANIAL MAGNETIC STIMULATION
FINGER PROTEIN 213
MOYAMOYA-DISEASE
RISK-FACTORS
INTRACRANIAL ANEURYSMS
期刊
N
IF:
60.6
论文数:
649
被引数:
3.8W
机构
引用论文
Tumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronchial needle aspiration: A pilot study.png)
Lung Cancer
Lung CancerIF0
PREAI
分享收藏Tolerability and antitumor activity of cemiplimab, a human monoclonal anti–PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohortLung Cancer
Lung CancerIF0
PREAI
分享收藏
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?Genes
OAAI
GenesIF0
OAAI分享收藏Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic StrokeNEUROLOGY
NEUROLOGYIF8.5
PREAI
分享收藏
查看更多内容